Dale Tronrud wrote: > The live form of the polio virus is the closest I know to the vaccination > campaign you describe.
I know something closer - it was called Welchia/Nachi and appeared in 2003 https://en.wikipedia.org/wiki/Welchia This did spark ethics discussions even when in this case human lives weren't (directly) at stake. As far as I can tell the consensus ultimately was that this is a bad idea, and it was noted that even the most well-intentioned effort can and will go wrong. https://www.technologyreview.com/2009/01/23/267877/why-a-good-worm-may-be-a-bad-idea/ Consent is of course the obvious primary concern. But can you also guarantee that your super-virus is clinically benign in everyone? (think: pregnant, neonatal, immuno-compromised, hypersensitive) And also: how could you prove that when your Phase 1 trial involves... literally everyone? I'm actually a trained vaccinator now, and we go to great lengths to only administer vaccines in very controlled settings. Apart from consent the administration is also controlled by a risk assessment regarding sensitivity to the vaccine and any of its ingredients, and we also observe people afterwards - so that in the rare case they do have an anaphylactoid reaction, vasovagal response, panic attack or anything else - immediate help is at hand. When people do suffer slower side-effects then you might be able to ascribe them to the vaccination. In any case you can go straight to the MHRA yellow card scheme. In the super-virus case you'd need to test people first. And I was under the impression that our health services are already quite busy. Speaking of side-effects - what side-effects would this campaign cause? And I don't mean just the individual/physiological. Think chemtrailers etc. - they would have a field day. Trust in medicine would take a nosedive for decades to come. So yeah - let's not do that. -Markus -- This e-mail and any attachments may contain confidential, copyright and or privileged material, and are for the use of the intended addressee only. If you are not the intended addressee or an authorised recipient of the addressee please notify us of receipt by returning the e-mail and do not use, copy, retain, distribute or disclose the information in or attached to the e-mail. Any opinions expressed within this e-mail are those of the individual and not necessarily of Diamond Light Source Ltd. Diamond Light Source Ltd. cannot guarantee that this e-mail or any attachments are free from viruses and we cannot accept liability for any damage which you may sustain as a result of software viruses which may be transmitted in or with the message. Diamond Light Source Limited (company no. 4375679). Registered in England and Wales with its registered office at Diamond House, Harwell Science and Innovation Campus, Didcot, Oxfordshire, OX11 0DE, United Kingdom ######################################################################## To unsubscribe from the CCP4BB list, click the following link: https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=CCP4BB&A=1 This message was issued to members of www.jiscmail.ac.uk/CCP4BB, a mailing list hosted by www.jiscmail.ac.uk, terms & conditions are available at https://www.jiscmail.ac.uk/policyandsecurity/
